Stability indicating high-performance thin-layer chromatographic determination of gatifloxacin as bulk drug and from polymeric nanoparticles

Analytica Chimica Acta

Volumn 576, Issue 2, 2006, Pages 253-260

  Motwani, Sanjay K ^a   Khar, Roop K ^a   Ahmad, Farhan J ^a   Chopra, Shruti ^a   Kohli, K ^a   Talegaonkar, Sushma ^a   Iqbal, Zeenat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Gatifloxacin; High performance thin layer chromatography; Stability indicating; Stress degradation; Validation

Indexed keywords

AMMONIA; HYDROLYSIS; NANOSTRUCTURED MATERIALS; POLYMERS; SILICA GEL; THIN LAYER CHROMATOGRAPHY;

GATIFLOXACIN; HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY; STABILITY INDICATING; STRESS DEGRADATION; VALIDATION;

ANTIBIOTICS;

ALUMINUM; AMMONIA; GATIFLOXACIN; METHANOL; NANOPARTICLE; POLYMER; PROPANOL; SILICON DIOXIDE; SOLVENT;

ACCURACY; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DENSITOMETRY; DRUG DETERMINATION; HEAT TREATMENT; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; LINEAR REGRESSION ANALYSIS; OXIDATION; PHOTODEGRADATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 33747092300     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2006.06.032     Document Type: Article

References (20)

1. Keam S.J., Croom K.F., and Keating G.M. Drugs 65 (2005) 695
2. Perry C.M., Balfour J.A.B., and Lamb H.M. Drugs 58 (1999) 683
3. Perry C.M., Ormrod D., Hurst M., and Onrust S.V. Drugs 62 (2002) 169
4. Saravolatz L.D., and Leggett J. Clin. Infect. Dis. 37 (2003) 1210
5. Lian N., Sun C.Y., and Zhao H.C. Fenxi Ceshi Xuebao 21 (2002) 79
6. Borner K., Hartwing H., and Lode H. Chromatographia 52 Supplement (2000) S105
7. Liang H., Kays M.B., and Sowinski K.M. J. Chromatogr. B 772 (2002) 53
8. Overholser B.R., Kays M.B., and Sowinski K.M. J. Chromatogr. B 798 (2003) 167
9. Shi A.X., He G.W., Li K.X., Liu L., and Sun C.H. Yaowu Fenxi Zazhi 23 (2003) 125
10. Zhou H.H., Gao S.M., Wang E.H., Shen W.B., and Sheng L.S. Yao Xue Xue Bao 37 (2002) 462
11. Vishwanathan K., Bartlett M.G., and Stewart J.T. Rapid Commun. Mass Spectrom. 15 (2001) 915
12. Shah S.A., Rathod I.S., Suhagia B.N., and Baldaniya M. Ind. J. Pharm. Sci. 66 (2004) 306
13. ICH, Q1A (R2) Stability Testing of New Drug Substances and Products, International Conference on Harmonization, Geneva, February, 2003 (http://www.ich.org/cache/compo/363-272-1.html#Q1A(R2).
14. Kulkarni S.P., and Amin P.D. J. Pharm. Biomed. Anal. 23 (2000) 983
15. Thoppil S.O., Cardoza R.M., and Amin P.D. J. Pharm. Biomed. Anal. 25 (2001) 15
16. Makhija S.N., and Vavia P.R. J. Pharm. Biomed. Anal. 25 (2001) 663
17. Kaul N., Agrawal H., Paradkar A.R., and Mahadik K.R. Anal. Chim. Acta 502 (2004) 31
18. Patravale V.B., D'Souza S., and Narkar Y. J. Pharm. Biomed. Anal. 25 (2001) 685
19. Ansari M.J., Ahmad S., Kohli K., Ali J., and Khar R.K. J. Pharm. Biomed. Anal. 39 (2005) 132
20. ICH, Q2 (R1), Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, Geneva, November, 2005 (http://www.ich.org/LOB/media/MEDIA417.pdf).